Patents by Inventor David Loffredo

David Loffredo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONTAINER FOR AN INHALATION ANESTHETIC
    Publication number: 20070221217
    Abstract: A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing one or more of polypropylene, polyethylene, and ionomeric resins. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
    Type: Application
    Filed: June 1, 2007
    Publication date: September 27, 2007
    Inventors: MARY FLAMENT-GARCIA, Keith Cromack, David Loffredo, Rajagopalan Raghavan, George Ramsay, Earl Speicher
  • Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid
    Publication number: 20060148906
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Application
    Filed: February 27, 2006
    Publication date: July 6, 2006
    Inventors: Christopher Bieniarz, Steve Chang, Keith Cromack, Shuyen Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl Speicher, Honorata Stelmach
  • Fluoroether compositions and methods for inhibiting their degradation in the presnce of a lewis acid
    Publication number: 20040048932
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Application
    Filed: June 26, 2003
    Publication date: March 11, 2004
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl R. Speicher, Honorate A. Stelmach
  • Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
    Patent number: 6677492
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Grant
    Filed: July 3, 2002
    Date of Patent: January 13, 2004
    Assignee: Abbott Laboratories
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl R. Speicher, Honorats A. Stelmach
  • Container for an inhalation anesthetic
    Publication number: 20030200963
    Abstract: A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing one or more of polypropylene, polyethylene, and ionomeric resins. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
    Type: Application
    Filed: April 4, 2003
    Publication date: October 30, 2003
    Inventors: Mary Jane Flament-Garcia, Keith R. Cromack, David Loffredo, Rajagopalan Raghavan, George M. Ramsay, Earl R. Speicher
  • Container for an inhalation anesthetic
    Patent number: 6558679
    Abstract: A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing one or more of polypropylene, polyethylene, and ionomeric resins. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
    Type: Grant
    Filed: December 19, 2000
    Date of Patent: May 6, 2003
    Assignee: Abbott Laboratories
    Inventors: Mary Jane Flament-Garcia, Keith R. Cromack, David Loffredo, Rajagopalan Raghavan, George M. Ramsay, Earl R. Speicher
  • Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
    Patent number: 6444859
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Grant
    Filed: August 8, 2001
    Date of Patent: September 3, 2002
    Assignees: Abbott Laboratories, Central Glass Company LTD
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl R. Speicher, Honorate A. Stelmach
  • Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid
    Publication number: 20020016373
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Application
    Filed: August 8, 2001
    Publication date: February 7, 2002
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl R. Speicher, Honorate A. Stelmach
  • Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
    Patent number: 6288127
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Grant
    Filed: November 23, 1999
    Date of Patent: September 11, 2001
    Assignee: Abbott Laboratories & Central Glass Co LTD
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl R. Speicher, Honorate A. Stelmach
  • Container for an inhalation anesthetic
    Publication number: 20010000729
    Abstract: A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing one or more of polypropylene, polyethylene, and ionomeric resins. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
    Type: Application
    Filed: December 19, 2000
    Publication date: May 3, 2001
    Inventors: Mary Jane Flament-Garcia, Keith R. Cromack, David Loffredo, Rajagopalan Raghavan, George M. Ramsay, Earl R. Speicher
  • Container for an inhalation anesthetic
    Patent number: 6162443
    Abstract: A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing one or more of polypropylene, polyethylene, and ionomeric resins. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: December 19, 2000
    Assignee: Abbott Laboratories
    Inventors: Mary Jane Flament-Garcia, Keith R. Cromack, David Loffredo, Rajagopalan Raghavan, George M. Ramsay, Earl R. Speicher
  • Polymethylpentene container for an inhalation anesthetic
    Patent number: 6083514
    Abstract: A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing polymethylpentene. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
    Type: Grant
    Filed: January 9, 1998
    Date of Patent: July 4, 2000
    Assignee: Abbott Laboratories
    Inventors: Steve H. Chang, Keith R. Cromack, Mary Jane Flament-Garcia, Joan Garapolo, David Loffredo, Rajagopalan Raghavan, George M. Ramsay, Patrick Rice, Jeffrey Setesak
  • Container for an inhalation anesthetic
    Patent number: 6074668
    Abstract: A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing polyethylene napthalate. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
    Type: Grant
    Filed: January 9, 1998
    Date of Patent: June 13, 2000
    Assignee: Abbott Laboratories
    Inventors: Mary Jane Flament-Garcia, Steve H. Chang, Keith R. Cromack, Joan Garapolo, David Loffredo, Rajagopalan Raghavan, George M. Ramsay, Patrick Rice, Jeffrey Setesak
  • Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
    Patent number: 5990176
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Grant
    Filed: January 27, 1997
    Date of Patent: November 23, 1999
    Assignees: Abbott Laboratories, Central Glass Company Ltd.
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl R. Speicher, Honorate A. Stelmach